๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Beijing
Clinical trial register · China

Clinical Trials in Beijing, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 7 Shenyang 5 Chongqing 2 Nanjing 2 Wuhu 2
Narrow the registerReset
Recruitment status
Phase
Site location
Beijing7 Shenyang5 Chongqing2 Nanjing2 Wuhu2
All 42 locations
Target enrolment
to

Trials with a site in Beijing

7 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Advancing Reperfusion Therapy for Ischemic Stroke: Perfusion-guided Endovascular Intervention for Medium Vessel Occlusion Therapy
NCT07323368Stroke Ischemic, Medium Vessel Occlusions
Beijing Tiantan Hospital
Not applicable
568
Beijing, Longzhou, Luoyang, Panlong, Changle
2026-02-08
Recruiting
Efficacy and Safety of Tenecteplase Bridging Mechanical Thrombectomy for Acute Large Vessel Occlusion Stroke
NCT06658197Stroke, Ischemic, Stroke, Acute, Thrombosis, Brain, Drug Effect
Xuanwu Hospital, Beijing
Phase 3
850
Beijing
2025-12-25
Recruiting
MPR for Stroke Risk Assessment of ICAS
NCT07309718ICAS - Intracranial Atherosclerosis, Stroke Ischemic, Hemodynamic
Xuanwu Hospital, Beijing
Observational
400
Beijing
2025-12-01
Recruiting
Advancing Reperfusion Therapy for Ischemic Stroke (ARTS): Tenecteplase in Medium Vessel Occlusion (MeVO) for Acute Ischemic Stroke
NCT07047014Stroke, Ischemic, Medium Vessel Occlusions
Beijing Tiantan Hospital
Phase 3
596
Beijing, Jiuquan, Shijiazhuang, Jiyuan, Lingbao, Nantong, Hangzhou
2025-07-30
Recruiting
Early Prophylactic Decompressive Hemicraniectomy Following Endovascular Therapy in Large Hemispheric Infarct Trial
NCT07118345Stroke, Ischemic, Cerebral Edema
Xuanwu Hospital, Beijing
Not applicable
380
Beijing, Shandong
2025-07-19
Recruiting
PET/MR Multimodal Quantitative Analysis of CBF and CMRGlc in Cerebral Ischemia
NCT07079345PET/MR, Stroke Ischemic
Xuanwu Hospital, Beijing
Observational
200
Beijing
2025-07-01
Recruiting
Neurovascular Product Surveillance Registry
NCT02988128Intracranial Aneurysm, Stroke, Ischemic
Medtronic Neurovascular Clinical Affairs
Observational
4,000
Beijing, Chongqing, Jiamusi, Jiโ€™an, Kaifeng, Liaocheng, Lishui, Nanchang
2016-12
Rows per page Showing 1–7 of 7
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 26 September 2026. https://priyalifescience.com/clinical-trials-china/city/beijing

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 7 of those studies with a site in Beijing that also match the filters currently applied.

How many clinical trials are recruiting in Beijing?

7 of the 7 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 0 have not yet opened recruitment, 0 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Beijing), 7 studies
PhaseStudiesRecruitingShare
Observational3342.9%
Not applicable2228.6%
Phase 32228.6%

Most active sponsors

Lead sponsors with the most studies (Beijing)
Lead sponsorStudiesRecruiting
Xuanwu Hospital, Beijing44
Beijing Tiantan Hospital22
Medtronic Neurovascular Clinical Affairs11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.